CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CLASSIC CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CLASSIC CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CLASSIC CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare hormone disorder: atumelnant trial launches
Disease control Recruiting nowThis study tests an experimental drug called atumelnant in 150 adults with classic congenital adrenal hyperplasia (CAH), a genetic condition that disrupts hormone production. Participants will receive either atumelnant or a placebo to see if the drug can better control hormone le…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 17, 2026 02:59 UTC
-
New hope for kids with rare hormone disorder: drug may cut steroid doses
Disease control Recruiting nowThis study tests a new medicine called atumelnant in children aged 1 to 18 with classic congenital adrenal hyperplasia, a genetic condition that disrupts hormone balance. The goal is to see if the drug can safely control hormone levels and reduce the need for daily steroid medica…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2, PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New hope for CAH: Long-Term drug trial launches
Disease control Recruiting nowThis study looks at the long-term safety and effectiveness of a drug called atumelnant (CRN04894) for people with classic congenital adrenal hyperplasia (CAH). About 150 adults who have already completed a previous study with this drug will continue treatment. Researchers will mo…
Matched conditions: CLASSIC CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC